Journal
CELL HOST & MICROBE
Volume 14, Issue 6, Pages 675-682Publisher
CELL PRESS
DOI: 10.1016/j.chom.2013.11.003
Keywords
-
Categories
Funding
- National Health and Medical Research Council (NHMRC) of Australia [1041294, 631386, 635250, 565526, 1041929, 606788]
- National Institutes of Health (NIH) of the United States of America [AI077780, AI057153, AR052728]
- National Health and Medical Research Council of Australia [631386] Funding Source: NHMRC
Ask authors/readers for more resources
Autophagy is reported to be an important innate immune defense against the intracellular bacterial pathogen Group A Streptococcus (GAS). However, the GAS strains examined to date belong to serotypes infrequently associated with human disease. We find that the globally disseminated serotype M1T1 clone of GAS can evade autophagy and replicate efficiently in the cytosol of infected cells. Cytosolic M1T1 GAS (strain 5448), but not M6 GAS (strain JRS4), avoids ubiquitylation and recognition by the host autophagy marker LC3 and ubiquitin-LC3 adaptor proteins NDP52, p62, and NBR1. Expression of SpeB, a streptococcal cysteine protease, is critical for this process, as an isogenic M1T1 Delta speB mutant is targeted to autophagy and attenuated for intracellular replication. SpeB degrades p62, NDP52, and NBR1 in vitro and within the host cell cytosol. These results uncover a proteolytic mechanism utilized by GAS to escape the host autophagy pathway that may underpin the success of the M1T1 clone.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available